Time-dependent degradation pattern of cardiac troponin T following myocardial infarction

Eline P M Cardinaels1, Alma M A Mingels, Tom van Rooij

  • 1Department of Clinical Chemistry, Maastricht University Medical Center, the Netherlands. mp.van.dieijen.visser@mumc.nl

Clinical Chemistry
|March 29, 2013
PubMed

Insights

Degraded cardiac troponin T (cTnT) forms are detected in acute myocardial infarction (AMI) patients

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Cardiology

Background:

  • Cardiac troponin T (cTnT) is a critical biomarker for diagnosing acute myocardial infarction (AMI).
  • The presence and detection of degraded cTnT forms in patient blood remain unclear.
  • Understanding cTnT forms is essential for accurate diagnostic assays.

Purpose of the Study:

  • To identify and characterize the different forms of cTnT circulating in AMI patients' sera.
  • To determine which cTnT forms are recognized by the clinical immunoassay.

Main Methods:

  • Serum samples from 13 AMI patients were analyzed using gel filtration chromatography (GFC) to separate cTnT forms.
  • Western blot analysis with antibodies from the Roche immunoassay was performed on GFC eluates.
  • Time-dependent degradation patterns were assessed using Western blot on serum samples from 18 AMI patients collected over 72 hours.

Main Results:

  • GFC revealed two distinct cTnT peaks, corresponding to fragments of approximately 29 kDa and 14-18 kDa.
  • Western blot analysis confirmed the presence of these fragments and indicated a time-dependent degradation of cTnT.
  • Intact cTnT (40 kDa) was detected in only a small subset of patients within the first 8 hours post-admission.

Conclusions:

  • The Roche cTnT immunoassay detects both intact and degraded forms of cTnT in AMI patients' sera.
  • cTnT undergoes time-dependent degradation following acute myocardial infarction.
  • These findings highlight the importance of considering cTnT degradation in diagnostic interpretations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...